Form 4: OneMedNet Director Increases Stake Through Conversions, Purchases

OneMedNet Corp director Thomas Kosasa significantly increased his beneficial ownership through a series of share acquisitions, loan conversions, and RSU grants.

Summary

• Director Thomas Kosasa of OneMedNet Corp acquired a total of 7,451,367 shares of common stock across multiple transactions.
• The acquisitions include 90,000 Restricted Stock Units (RSUs) granted as director compensation for fiscal years 2024 and 2025, vesting on December 31, 2024, and December 31, 2025, respectively.
• He converted senior secured convertible notes (PIPE Notes) into 493,056 shares of common stock at a conversion price of $1.14 per share on June 17, 2025.
• Approximately $1.6 million in outstanding principal from convertible shareholder loans was converted into 2,123,424 shares on June 19, 2025.
• An additional approximately $2.0 million of outstanding principal and accrued interest under shareholder and business combination extension loans was converted into 2,865,016 shares on June 19, 2025.
• Through subscription agreements, Kosasa purchased 1,190,476 shares at $0.42 per share on June 20, 2025, and 581,395 shares at $0.86 per share on August 29, 2025, providing a total of $1,000,000 in gross proceeds to OneMedNet Corp.
• Further direct purchases included 47,000 shares at $0.4864 on April 21, 2025, 55,000 shares at $0.3821 on June 16, 2025, and 6,000 shares at $0.9331 on September 24, 2025.
• Following these reported transactions, Thomas Kosasa beneficially owns 15,785,191 shares of OneMedNet Corp common stock.

Sentiment

Score: 8

Explanation: The significant increase in beneficial ownership by a director, including direct purchases and conversion of loans into equity, indicates strong insider confidence and provides capital to the company, which is generally a positive signal for investors.

Positives

• Director Thomas Kosasa significantly increased his beneficial ownership, demonstrating strong insider confidence in OneMedNet Corp.
• The company received $1,000,000 in gross proceeds from share purchases by the director through subscription agreements.
• Conversion of shareholder loans and convertible notes into equity reduces the company's debt obligations, potentially improving its financial structure.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the vesting schedules of RSUs and the maturity/conversion terms of existing financial instruments.

Industry Context

This Form 4 filing primarily details insider transactions and does not provide sufficient information to analyze broader industry trends or competitive positioning. However, significant insider buying can signal confidence in the company's future within its sector.

Related Party Transactions

• Conversion of approximately $1.6 million in outstanding principal under certain convertible shareholder loans previously made by the reporting person to the issuer.
• Conversion of approximately $2.0 million of outstanding principal and accrued interest under certain shareholder loans and business combination extension loans with the reporting person.
• Subscription agreements where the issuer sold shares to the reporting person, providing $1,000,000 in gross proceeds to the issuer.

Stakeholder Impact

• Shareholders: Increased insider ownership may signal confidence, potentially positively influencing investor sentiment. The conversions and new share sales to the director result in dilution for existing shareholders.
• Creditors: Conversion of shareholder loans into equity reduces the company's debt burden, potentially improving its financial structure.

Next Steps

• Vesting of 45,000 RSUs on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

Key Dates

Recommendation

While the significant increase in director ownership through various means, including direct purchases and conversion of debt to equity, signals strong insider confidence and provides capital to the company, a Form 4 filing alone does not provide sufficient operational or financial performance data to warrant a 'buy' or 'strong buy' recommendation. It's a positive indicator, but further analysis of the company's fundamentals, market position, and overall financial health is required for a more definitive investment stance. The conversion of debt to equity is positive for the balance sheet, but the dilution effect on existing shareholders needs to be considered. Therefore, a 'hold' recommendation is appropriate, pending a deeper dive into the company's broader financial disclosures.

Keywords

OneMedNet Corp, ONMD, Form 4, Insider Trading, Director Stock Acquisition, Shareholder Loans, Convertible Notes, Equity Incentive Plan, Restricted Stock Units, Insider Ownership